Tripeptide analogues of MG132 as protease inhibitors

Bioorg Med Chem. 2019 Jan 15;27(2):436-441. doi: 10.1016/j.bmc.2018.12.022. Epub 2018 Dec 14.

Abstract

The 26S proteasome and calpain are linked to a number of important human diseases. Here, we report a series of analogues of the prototypical tripeptide aldehyde inhibitor MG132 that show a unique combination of high activity and selectivity for calpains over proteasome. Tripeptide aldehydes (1-3) with an aromatic P3 substituent show enhanced activity and selectivity against ovine calpain 2 relative to chymotrypsin-like activity of proteasome. Docking studies reveal the key contacts between inhibitors and calpain to confirm the importance of the S3 pocket with respect to selectivity between calpains 1 and 2 and the proteasome.

Keywords: 26S proteasome inhibitors; Calpain inhibitors; Medicinal chemistry; Peptidomimetics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antimalarials / chemical synthesis
  • Antimalarials / chemistry
  • Antimalarials / pharmacology
  • Calpain / chemistry
  • Catalytic Domain
  • Cysteine Proteinase Inhibitors / chemical synthesis
  • Cysteine Proteinase Inhibitors / chemistry
  • Cysteine Proteinase Inhibitors / pharmacology*
  • Leupeptins / chemical synthesis
  • Leupeptins / chemistry
  • Leupeptins / pharmacology*
  • Molecular Docking Simulation
  • Molecular Structure
  • Plasmodium falciparum / enzymology
  • Proteasome Endopeptidase Complex / chemistry
  • Proteasome Inhibitors / chemical synthesis
  • Proteasome Inhibitors / chemistry
  • Proteasome Inhibitors / pharmacology*
  • Protein Conformation
  • Rats
  • Sheep
  • Swine

Substances

  • Antimalarials
  • Cysteine Proteinase Inhibitors
  • Leupeptins
  • Proteasome Inhibitors
  • Calpain
  • Proteasome Endopeptidase Complex
  • ATP dependent 26S protease
  • benzyloxycarbonylleucyl-leucyl-leucine aldehyde